Jan 18, 2024, 08:45
Carbiotix (publ) ("Carbiotix" or the "Company") announces today that the Company has completed the second phase of the CarbiAXOS production upgrade at the Company’s pilot production site in Bjuv, Sweden. The upgrade involved the commissioning of a new spray dryer, enabling the production of Carbiotix’s second-generation CarbiAXOS prebiotic ingredient. Furthermore, the Company has also hired Calle Sjöström as new Chief Process Engineer. Calle will be joining the management team and taking responsibility for the scale-up of CarbiAXOS production in Bjuv and with partners.
Carbiotix announces today the successful completion of phase two of the production upgrade at the Company’s pilot production site in Bjuv, Sweden. The recent upgrade marks another important step in CarbiAXOS production capabilities and is a key component in Carbiotix’s strategic plan to accelerate the creation of high-end CarbiAXOS products. To drive the scale-up of CarbiAXOS in Sweden and abroad, Carbiotix has hired Calle Sjöström as Chief Process Engineer. Calle holds a Ph.D. from LTH, Sweden and has over 20 years of industrial experience, with 10 years of experience in the management of food & beverage production processes.
Erik Deaner, CEO of Carbiotix comments:
"Both the completion of the CarbiAXOS process upgrade in Bjuv and hiring of a Chief Process Engineer are key milestones for Carbiotix. The commissioning of the spray dryer will allow us to produce CarbiAXOS for customers and others, as well as accelerate product development activities. I am also very happy to welcome Calle Sjöström as our Chief Process Engineer and look forward to Calle joining the management team and driving forward the scale-up of CarbiAXOS production in Bjuv and through our partners. Calle’s wealth of experience will most definitely help us accelerate product development activities as well as a cost effective and reliable production of CarbiAXOS.”
This communication contains forward-looking statements, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as of the date they are made and are, by their nature, as is research and development work in the biotechnology segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios as described in this press release.
For further information:
Erik Deaner, CEO
Tel: +46 (0)738 67 30 85
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome healthcare through a portfolio of prebiotic modulators and diagnostic testing services.